Evaluation of the safety of C-1311 (SYMADEX) administered in a phase 1 dose escalation trial as a weekly infusion for 3 consecutive weeks in patients with advanced solid tumours

✍ Scribed by N. Isambert; M. Campone; E. Bourbouloux; M. Drouin; A. Major; W. Yin; P. Loadman; R. Capizzi; C. Grieshaber; P. Fumoleau

• Book ID: 116430244
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 124 KB
• Volume: 46
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2009.12.005